Bowhead Specialty (NYSE:BOW) Price Target Raised to $34.00

Bowhead Specialty (NYSE:BOWFree Report) had its price objective increased by Keefe, Bruyette & Woods from $31.00 to $34.00 in a report issued on Wednesday morning,Benzinga reports. They currently have an outperform rating on the stock.

BOW has been the topic of a number of other research reports. Citizens Jmp dropped their price target on Bowhead Specialty from $38.00 to $35.00 and set a “market outperform” rating on the stock in a research note on Monday, April 13th. Royal Bank Of Canada dropped their price target on Bowhead Specialty from $33.00 to $30.00 and set an “outperform” rating on the stock in a research note on Wednesday, February 25th. Weiss Ratings upgraded Bowhead Specialty from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, May 8th. Morgan Stanley boosted their price target on Bowhead Specialty from $25.00 to $27.00 and gave the stock an “equal weight” rating in a research note on Tuesday. Finally, Zacks Research upgraded Bowhead Specialty from a “strong sell” rating to a “hold” rating in a research note on Tuesday, February 24th. Five research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to MarketBeat.com, Bowhead Specialty presently has an average rating of “Moderate Buy” and an average price target of $31.83.

View Our Latest Report on BOW

Bowhead Specialty Price Performance

Shares of BOW stock opened at $28.21 on Wednesday. Bowhead Specialty has a fifty-two week low of $21.21 and a fifty-two week high of $39.33. The firm has a market capitalization of $926.51 million, a price-to-earnings ratio of 16.31, a PEG ratio of 0.81 and a beta of -0.15. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.47 and a current ratio of 0.47. The stock’s 50-day simple moving average is $23.84 and its 200-day simple moving average is $25.27.

Bowhead Specialty (NYSE:BOWGet Free Report) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $0.48 earnings per share for the quarter, topping analysts’ consensus estimates of $0.42 by $0.06. Bowhead Specialty had a return on equity of 13.80% and a net margin of 9.99%.The business had revenue of $155.69 million for the quarter, compared to analyst estimates of $211.74 million. As a group, equities analysts forecast that Bowhead Specialty will post 1.98 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Bowhead Specialty

Institutional investors and hedge funds have recently modified their holdings of the company. Langdon Equity Partners acquired a new stake in shares of Bowhead Specialty during the fourth quarter worth about $28,000. Raymond James Financial Inc. acquired a new stake in shares of Bowhead Specialty during the second quarter worth about $52,000. CWM LLC lifted its holdings in shares of Bowhead Specialty by 257.7% during the fourth quarter. CWM LLC now owns 1,481 shares of the company’s stock worth $42,000 after purchasing an additional 1,067 shares during the period. State of Alaska Department of Revenue acquired a new stake in shares of Bowhead Specialty during the third quarter worth about $42,000. Finally, Parallel Advisors LLC lifted its holdings in shares of Bowhead Specialty by 181.4% during the first quarter. Parallel Advisors LLC now owns 1,652 shares of the company’s stock worth $37,000 after purchasing an additional 1,065 shares during the period.

About Bowhead Specialty

(Get Free Report)

Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.

Featured Stories

Analyst Recommendations for Bowhead Specialty (NYSE:BOW)

Receive News & Ratings for Bowhead Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bowhead Specialty and related companies with MarketBeat.com's FREE daily email newsletter.